Flonase and Abraxane drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flonase (fluticasone propionate) and Abraxane (paclitaxel). Common drug interactions include atrophic vulvovaginitis among females and vomiting among males.

The phase IV clinical study analyzes what interactions people have when they take Flonase and Abraxane. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Abraxane?

Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. eHealthMe is studying from 19,196 Abraxane users. Check the latest studies of Abraxane.



On Jul, 22, 2026

47 people who take Flonase and Abraxane together, and have interactions are studied.

Flonase and Abraxane drug interactions.

What are the common drug interactions of Flonase and Abraxane, by gender? *:

female:

  1. Atrophic vulvovaginitis (inflammation of the vulva)
  2. Atrophy (wasting away of a part of the body)
  3. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  4. Bone pain
  5. Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
  6. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  7. Breast disorder
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  10. Cataract (clouding of the lens inside the eye)

male:

  1. Vomiting
  2. Dyspnoea (difficult or laboured respiration)
  3. Gastric ulcer perforation (stomach hole due to ulcer)
  4. Haematocrit decreased
  5. Haemoglobin decreased
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Hypotension (abnormally low blood pressure)
  8. Infection
  9. Liver abscess (pus in liver)
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Flonase and Abraxane, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Gastroenteritis (inflammation of stomach and intestine)
  2. Anxiety
  3. Diarrhoea
  4. Haemoglobin decreased
  5. White blood cell count decreased
  6. Abdominal pain
  7. Abscess limb (limb infection)
  8. Abscess rupture (pus release from the point of abscess)
  9. Aortic arteriosclerosis (hardening of the aortic arteries)
  10. Aortic calcification (aortic calcification sign of heart valve disease)

50-59:

  1. Pericardial effusion (fluid around the heart)
  2. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  3. Platelet count decreased
  4. Pleural effusion (water on the lungs)
  5. Purulent discharge (discharge that contains pus)
  6. Pyrexia (fever)
  7. Rash
  8. Swelling face
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Synovial disorder (disease of synovial joint)

60+:

  1. Anaemia (lack of blood)
  2. Hypotension (abnormally low blood pressure)
  3. Fatigue (feeling of tiredness)
  4. Herpes zoster
  5. Infusion site bruising
  6. Neoplasm malignant (cancer tumour)
  7. Pancreatic carcinoma (pancreatic cancer)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Vomiting
  10. Weight decreased

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 21 people, 44.68%
  2. Pain: 11 people, 23.40%
  3. Diarrhea: 9 people, 19.15%
  4. Nausea And Vomiting: 8 people, 17.02%
  5. Immunodeficiency Common Variable: 7 people, 14.89%
  6. Itching: 6 people, 12.77%
  7. High Blood Pressure: 6 people, 12.77%
  8. Hypersensitivity: 6 people, 12.77%
  9. Pancreatic Carcinoma (pancreatic cancer): 5 people, 10.64%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 10.64%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and Abraxane?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flonase and Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flonase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abraxane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flonase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abraxane and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate and paclitaxel (the active ingredients of Flonase and Abraxane, respectively), and Flonase and Abraxane (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: